Our results are consistent with those reported by Oikonomou et al. [17] who noticed that the measurements of serum NGAL concentration can differentiate patients with IBD from healthy subjects or patients with irritable bowel syndrome. Here, LCN2 is linked to irritable bowel syndrome.